|
|
Compact Navigation System for CT-guided Needle Interventions
|
1UT1CA224886-01A1
|
$149,927
|
$149,927
|
TSE, TSZ HO
|
3T TECHNOLOGIES, LLC
|
|
|
Personalized precision dosing of biologic therapies in oncology
|
5R44CA217336-02
|
$720,363
|
$720,363
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
|
Novel Glyco-tests to Predict Chemoresistance
|
3R43CA213766-01A1S1
|
$50,000
|
$50,000
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
|
Novel Glyco-tests to Predict Chemoresistance
|
3R43CA213766-01A1S2
|
$149,785
|
$149,785
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
|
Image-guided ultrasound ablation for precision targeting of prostate cancer
|
1R01CA230323-01
|
$580,217
|
$580,217
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
|
Innovation Corp Program and Commercialization Planning for Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone
|
3R43CA225169-01S1
|
$49,999
|
$49,999
|
SNOOK, KEVIN
|
ACTUATED MEDICAL, INC.
|
|
|
Fluorescent Nanodiamonds for Multiplexed Imaging and Diagnostics
|
1R43CA232901-01
|
$291,083
|
$291,083
|
SHENDEROVA, OLGA
|
ADAMAS NANOTECHNOLOGIES, INC.
|
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
$1,111,364
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
|
The Hemopurifier Device for Targeted Removal of Breast Cancer Exosomes from the Blood Circulation
|
1R43CA232977-01
|
$298,444
|
$298,444
|
MARLEAU, ANNETTE
|
AETHLON MEDICAL, INC.
|
|
|
Novel Strategies for Precision T-cell Therapies
|
3R01CA198095-03S1
|
$107,431
|
$107,431
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
$520,564
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$145,846
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S1
|
$2,000
|
$2,000
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S2
|
$126,060
|
$126,060
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
|
Molecular, cancer-specific, intraoperative imaging of breast surgical margin assessment
|
1R41CA221595-01A1
|
$300,000
|
$300,000
|
SHIH, WEI-HENG
|
AQD LIFE SCIENCES, LLC
|
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-03
|
$378,392
|
$378,392
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Create three-member project team to refine commercialization plans for AML-Mutation Counter, a tool to detect residual and recurrent leukemia.
|
3R41CA213690-01S1
|
|
$0
|
KAUFMANN, WILLIAM
|
ASYSTBIO LABORATORIES, LLC
|
|
|
SPORE in Lymphoma
|
5P50CA126752-12
|
$2,297,796
|
$275,736
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
$625,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$25,432
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$8,650
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$438
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Multifunctional immunoPET tracers for pancreatic and prostate cancer
|
7R01CA174294-06
|
$377,890
|
$377,890
|
WU, ANNA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
|
1R01CA218382-01A1
|
$668,549
|
$668,549
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
|
1R01CA228029-01A1
|
$688,217
|
$688,217
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
$522,325
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Parallel and high throughput isolation of cfDNA to target detection of rare, highly conserved nucleotide polymorphisms
|
1R43CA228923-01A1
|
$286,548
|
$286,548
|
MULLER, ROLF
|
BIOFLUIDICA, INC
|
|
|
Parallel and high throughput isolation of cancer cell derived extracellular vesicles
|
1R43CA232848-01
|
$239,138
|
$239,138
|
MULLER, ROLF
|
BIOFLUIDICA, INC
|
|
|
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications
|
1R01CA224911-01A1
|
$715,647
|
$715,647
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
|
Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level
|
1R33CA223581-01A1
|
$390,880
|
$390,880
|
CHENG, JI-XIN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Overcoming Tumor Resistance to Chemotherapy with Multiscale Diffuse and Nonlinear Imaging
|
5F99CA223014-02
|
$32,917
|
$32,917
|
KARROBI, KAVON
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Clinical Feasibility of Chemotherapy Monitoring for Sarcoma with Diffuse Optical Spectroscopic Imaging
|
1F31CA221074-01A1
|
$38,082
|
$38,082
|
PETERSON, HANNAH
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
|
5R01CA138509-10
|
$368,325
|
$368,325
|
REINHARD, BJOERN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Implantable microdevices with integrated optical imaging for high-throughput in situ tumor response and drug sensitivity measurement
|
1R37CA224144-01A1
|
$401,059
|
$401,059
|
JONAS, OLIVER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Engineering personalized micro-tumor ecosystems
|
5U01CA214411-02
|
$754,767
|
$754,767
|
SENGUPTA, SHILADITYA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
High-speed panoramic 3D photoacoustic computed tomography of the breast
|
1R35CA220436-01A1
|
$802,428
|
$802,428
|
WANG, LIHONG
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
$394,657
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
$17,498
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
$3,360
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Computational Genomic Epidemiology of Cancer (CoGEC) Training Program
|
5T32CA094186-17
|
$280,737
|
$70,184
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Computerized histologic image predictor of cancer outcome
|
5R01CA202752-03
|
$608,223
|
$608,223
|
MADABHUSHI, ANANT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
|
5R01CA196687-04
|
$522,225
|
$522,225
|
MUZIC, RAYMOND
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
FrostBite - A Unique Catheter for Endoscopic Cryoablation
|
5R44CA183265-03
|
$737,450
|
$737,450
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
|
A Unique Deployable Thermosensor Probe for the Minimally Invasive Treatment of Renal Tumors
|
1R43CA224431-01A1
|
$300,000
|
$300,000
|
VAN BUSKIRK, ROBERT
|
CELL PRESERVATION SERVICES, INC.
|
|
|
Programmable Individualized NRT Merged With Digital Behavioral Support
|
5R44CA171786-05
|
$1,000,000
|
$1,000,000
|
LEVY, ALAN
|
CHRONO THERAPEUTICS, INC.
|
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach(2 of 2)
|
3U54CA132378-10S1
|
$250,000
|
$22,500
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
|
5R44CA210770-03
|
$570,035
|
$570,035
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
|
Microfluidic Magnetic Anisotropic Array for High-throughput Isolation of Extracellular Vesicles and Exosomes
|
1R43CA221536-01A1
|
$255,980
|
$255,980
|
WEST, JAMES
|
CLARA DIAGNOSTICS, INC.
|
|
|
Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment
|
2R44CA206801-02
|
$920,127
|
$920,127
|
HAN, XIAO
|
CLARIX IMAGING CORPORATION
|
|
|
Tablet-Based Augmented Reality for Fast CT Guidance with Reduced Radiation
|
1R43CA228865-01
|
$224,529
|
$224,529
|
FOROUGHI, PEZHMAN
|
CLEAR GUIDE MEDICAL, INC.
|
|
Total relevant funding to Bioengineering for this search: $187,182,751
|
